What is new about axonal damage is the question if neuropathological properties of inflammatory lesion activity, neuroaxonal injury, or neurodegeneration correlate with axonal damage, as reflected by CSF NfL levels in MS [29,30]. This evidence concerns the gene NEFL and myeloid sarcoma.